Article Abstract

What is the contemporary role for surgery in the management of malignant pleural mesothelioma?

Authors: David Waller, Annabel Sharkey


Malignant pleural mesothelioma (MPM) is a relatively locally invasive, asbestos-related cancer responsible for almost 40,000 deaths worldwide annually (1). In the US and many Western European countries, including the UK, its incidence is increasing in view of the time lag of 30–50 years after exposure to asbestos. In the Western world, mesothelioma incidence is expected to be reaching a peak around 2020 with subsequent gradual decline.